Remission of schizophrenia in Indonesia: An outpatient-based 12-month follow-up study

Khamelia Malik, Nurmiati Amir, A. A.A.A. Kusumawardhani, Mutia Sari, Yolla Disty Arista, Narjas, Rhapsody Nanda

Research output: Contribution to journalArticlepeer-review

Abstract

This study assessed the achievement of remission criteria among schizophrenic outpatients in Indonesia and detected the most significant factors involved in this process. A 12-month follow-up was conducted to assess symptomatic remission was conducted at Cipto Mangunkusumo Hospital. Inclusion criteria were outpatients with an International Classification of Diseases 10th edition diagnosis of schizophrenia and schizoaffective disorder. Symptomatic remission was assessed using the Positive and Negative Syndrome Scale (PANSS) criteria (i.e., low scores for symptom 8-cores of PANSS for ≥6 consecutive months). At 6 months, approximately 137 (61%) of 223 outpatients met the criteria for symptomatic remission, and at the end of 12-month follow-up period, 64 (80%) of 80 outpatients achieved remission. Among these, 16 (20%) patients did not fulfill the remission criteria. A significant correlation was found between remission and the Global assessment of functioning (GAF) score. Remission was associated with family history of mental illness, onset of illness, type of antipsychotics, and prescription pattern. After 12 months, 80% of our schizophrenic outpatients achieved remission. Early onset of illness, family history of mental illness, use of first-generation antipsychotics, and poly-pharmacy were associated with poor remission rates. Some of these factors are potentially modifiable and should become targets for clinical care.

Original languageEnglish
Pages (from-to)238-241
Number of pages4
JournalJournal of International Dental and Medical Research
Volume12
Issue number1
Publication statusPublished - 1 Jan 2019

Keywords

  • 1-year follow-up
  • Remission
  • Schizophrenia

Fingerprint Dive into the research topics of 'Remission of schizophrenia in Indonesia: An outpatient-based 12-month follow-up study'. Together they form a unique fingerprint.

Cite this